Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants-Reference-Cited by-同舟云学术

Immunogenicity of a combined schedule of 7-valent pneumococcal conjugate vaccine followed by a 23-valent polysaccharide vaccine in adult recipients of heart or lung transplants

Published:2011-04-13 Issue:5 Volume:13 Page:540-544
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:

Author:

Gattringer R.,Winkler H.,Roedler S.,Jaksch P.,Herkner H.,Burgmann H.

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1399-3062.2011.00628.x/fullpdf

Reference18 articles.

1. Invasive pneumococcal disease in solid organ transplant recipients - 10-year prospective population surveillance;Kumar;Am J Transplant,2007

2. Guidelines for vaccination of solid organ transplant candidates and recipients;Danzinger-Isakov;Am J Transplant,2009

3. Immunogenicity of pneumococcal vaccine in heart transplant recipients;Blumberg;Clin Infect Dis,2001

4. Impaired anti-pneumococcal polysaccharide antibody production and invasive pneumococcal infection following heart transplantation;Sarmiento;Int Immunopharmacol,2006

5. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults;de Roux;conjugate vaccine elicits improved antibacterial immune responses and immunological memory,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety of double dosage of pneumococcal vaccines in adult kidney transplant recipients and waiting list patients: A non-blinded, randomized clinical trial;Vaccine;2022-06

2. Bacterial infections in lung transplantation;Journal of Thoracic Disease;2021-11

3. Vaccination and their importance for lung transplant recipients in a COVID-19 world;Expert Review of Clinical Pharmacology;2021-08-10

4. A randomized, controlled trial comparing the immunogenecity and safety of a 23‐valent pneumococcal polysaccharide vaccination to a repeated dose 13‐valent pneumococcal conjugate vaccination in kidney transplant recipients;Transplant Infectious Disease;2020-06-23

5. Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients;Transplantation Direct;2020-05-21